Supplements and Featured Publications
Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 2
Volume: 1
Issue: 2
Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 1
Volume: 1
Issue: 1
Updates and Advances in Basal Cell Carcinoma
Volume: 2
Issue: 2
SABCS 2020: Reflections in HER2+ Breast Cancer
Volume: 1
Issue: 1
Current and Emerging Trends in Chronic Myeloid Leukemia
Volume: 1
Issue: 1
My Treatment Approach: Locally Advanced Lung Cancer
Volume: 1
Issue: 1
Utilizing Tumor Metabolism in Solid Malignancies
Volume: 1
Issue: 1
Updates in ESR1-Mutant Breast Cancer
Volume: 1
Issue: 1
My Treatment Approach: Multiple Myeloma
Volume: 1
Issue: 1
My Treatment Approach: Chronic Lymphocytic Leukemia
Volume: 1
Issue: 1
Advances in Immunotherapy in Metastatic Non–Small Cell Lung Cancer
Volume: 1
Issue: 1
Role of Trop-2 as an Actionable Biomarker in Solid Tumors
Volume: 1
Issue: 1
The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer
Volume: 1
Issue: 1
ESMO 2020 Congress: Focus in Genitourinary Cancers
Volume: 1
Issue: 1
Updates and New Targets in NSCLC: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
2020 EBMT Meeting Reporter
Volume: 1
Issue: 1
Considerations for the Management of Interstitial Lung Disease With Novel Treatments in HER2+ Breast Cancer, Lung Cancers, and Gastrointestinal Cancers
Volume: 1
Issue: 1
Year in Review: Updates in DLBCL Treatment
Volume: 1
Issue: 1
Updates in Relapsed/Refractory Metastatic Renal Cell Carcinoma: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
Current and Emerging Treatments in Follicular Lymphoma
Volume: 1
Issue: 1
Antibody-Drug Conjugates in HER2+ Breast Cancer
Volume: 1
Issue: 1
New Developments in the Use of Immunotherapy for the Treatment of Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
Volume: 1
Issue: 1
2020 World GI: Updates in HER2+ GI Cancers
Volume: 1
Issue: 1
Exploring Therapeutic Strategies in Myelodysplastic Syndromes
Volume: 2020
Issue: 1
Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Volume: 1
Issue: 1
OncLive® provides updates on the treatment of patients with diffuse large B-cell lymphoma through a Scientific Exchange Workshop.
ASCO 2020: Update on Genitourinary Cancers
Volume: 1
Issue: 1
Advanced HER2-Expressing Breast Cancer: An OncLive® Scientific Interchange and Workshop
Volume: 1
Issue: 1
My Treatment Approach: HER2-Positive Breast Cancer
Volume: 1
Issue: 1
Year in Review: Evolving Landscape in Multiple Myeloma
Volume: 1
Issue: 1
Therapeutic Changes in HER2+ Breast Cancer
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5